Neuroscience Center News

In this Q&A, Dr. Heim discusses her clinical interests and her thoughtful, strategic approach to caring for patients with genetic movement disorders.

Children’s Hospital of Philadelphia (CHOP) announced today a $50 million gift from Einhorn Collaborative to establish the David M. Einhorn Institute for Early Relational Health (Einhorn Institute), advancing a new frontier in pediatric care focused on the science of human connection and its impact on health.

The award will fund the Pediatric Epilepsies and Rare CNS (PERC) Gene Editing Platform – a collaboration of academic researchers, clinicians, patient advocates, and biotechnology companies aiming to develop gene-editing treatments for children with rare forms of epilepsy.

The network was established by a five-year grant of up to $17.25 million awarded by ARIA.

D3B is among several institutions that will help scale a national pediatric data and knowledge network to improve health outcomes for children with complex diseases, beginning with pediatric brain cancer.

This study helps to clarify the natural progression of the disorder over the lifespan and emphasizing the urgent need for precision medicine approaches to treat these disorders.

Advanced surgical techniques are leading to life-changing results for children with drug-resistant epilepsy.

A new study has found that certain forms of epilepsy caused by genetic mutations have distinct signatures that can be observed via EEG.

Certification recognizes excellence in clinical care and research and highlights CHOP’s commitment to advancing care for children living with muscular dystrophy.

Read this case study to learn how spinal surgery can help improve mobility for children with spastic diplegic cerebral palsy.